A Mucoadhesive Polymer Extracted from Tamarind Seed Improves the Intraocular Penetration and Efficacy of Rufloxacin in Topical Treatment of Experimental Bacterial Keratitis
暂无分享,去创建一个
E. Ghelardi | M. Campa | A. Tavanti | S. Senesi | F. Celandroni | S. Salvetti | E. Boldrini | P. Davini | E. Parisio
[1] A. Ludwig,et al. The use of mucoadhesive polymers in ocular drug delivery. , 2005, Advanced drug delivery reviews.
[2] L. Laroche,et al. Bacterial keratitis: predisposing factors, clinical and microbiological review of 300 cases , 2003, The British journal of ophthalmology.
[3] R. Cavalli,et al. Solid lipid nanoparticles (SLN) as ocular delivery system for tobramycin. , 2002, International journal of pharmaceutics.
[4] L. Zografos,et al. Bacterial keratitis: a prospective clinical and microbiological study , 2001, The British journal of ophthalmology.
[5] S. Burgalassi,et al. Gel-forming erodible inserts for ocular controlled delivery of ofloxacin. , 2001, International journal of pharmaceutics.
[6] P. McDonnell,et al. Bacteriologic and Clinical Efficacy of Ofloxacin 0.3% Versus Ciprofloxacin 0.3% Ophthalmic Solutions in the Treatment of Patients with Culture-positive Bacterial Keratitis , 2001, Cornea.
[7] H. Taylor,et al. Increased incidence of corneal perforation after topical fluoroquinolone treatment for microbial keratitis. , 2001, American journal of ophthalmology.
[8] E. Ghelardi,et al. Effect of a novel mucoadhesive polysaccharide obtained from tamarind seeds on the intraocular penetration of gentamicin and ofloxacin in rabbits. , 2000, The Journal of antimicrobial chemotherapy.
[9] G. Alexandrakis,et al. Shifting trends in bacterial keratitis in south Florida and emerging resistance to fluoroquinolones. , 2000, Ophthalmology.
[10] H. Taylor,et al. Fluoroquinolone and fortified antibiotics for treating bacterial corneal ulcers , 2000, The British journal of ophthalmology.
[11] G. Banchelli,et al. A New Viscosity Enhancer for Ophthalmic Preparations Devoid of Toxicity for Human Conjunctival Cells , 2000 .
[12] S. Pauluzzi,et al. Penetration of Rufloxacin into the Cerebrospinal Fluid in Patients with Inflamed and Uninflamed Meninges , 2000, Antimicrobial Agents and Chemotherapy.
[13] H. Dua,et al. Antimicrobial defensin peptides of the human ocular surface , 1999, The British journal of ophthalmology.
[14] S. Burgalassi,et al. Development of a Simple Dry Eye Model in the Albino Rabbit and Evaluation of Some Tear Substitutes , 1999, Ophthalmic Research.
[15] K. Mcclellan. Mucosal defense of the outer eye. , 1997, Survey of ophthalmology.
[16] James M. Hill,et al. Ocular drug delivery: A comparison of transcorneal iontophoresis to corneal collagen shields , 1995 .
[17] James M. Hill,et al. Pharmacokinetic Considerations in the Treatment of Bacterial Keratitis , 1994, Clinical pharmacokinetics.
[18] R. Snyder,et al. Penetration of topically applied ciprofloxacin, norfloxacin, and ofloxacin into the aqueous humor. , 1994, Ophthalmology.
[19] J. Hadgraft,et al. Evaluation of Mucoadhesive Polymers in Ocular Drug Delivery. II. Polymer-Coated Vesicles , 1992, Pharmaceutical Research.
[20] M. Ligtenberg,et al. Cell membrane-associated mucins and their adhesion-modulating property. , 1992, Trends in biochemical sciences.
[21] R. Wise,et al. The in-vitro activity of two new quinolones: rufloxacin and MF 961. , 1992, The Journal of antimicrobial chemotherapy.
[22] B. Imbimbo,et al. Pharmacokinetics and tissue penetration of rufloxacin, a long acting quinolone antimicrobial agent. , 1991, The Journal of antimicrobial chemotherapy.
[23] A. Oomomo. [Pseudomonas aeruginosa ocular infection]. , 1991, Nihon rinsho. Japanese journal of clinical medicine.
[24] J. Hadgraft,et al. Evaluation of Mucoadhesive Polymers in Ocular Drug Delivery. I. Viscous Solutions , 1991, Pharmaceutical Research.
[25] J. A. Hobden,et al. The role of pneumolysin in ocular infections with Streptococcus pneumoniae. , 1990, Current eye research.
[26] J. Bosso,et al. The comparative in vitro activity of ofloxacin and selected ophthalmic antimicrobial agents against ocular bacterial isolates. , 1989, American journal of ophthalmology.
[27] C. Basbaum,et al. Platelet-activating factor receptor and ADAM10 mediate responses to Staphylococcus aureus in epithelial cells , 2002, Nature Medicine.
[28] P. Garg,et al. Bilateral infectious keratitis after laser in situ keratomileusis: a case report and review of the literature. , 2001, Ophthalmology.
[29] G. Banchelli,et al. Effect of Xyfoglucan (Tamarind Seed Polysaccharide) on Conjunctival Cell Adhesion to Laminin and on Corneal Epithelium Wound Healing , 2000, European journal of ophthalmology.
[30] Sibel Özyazgan,et al. Penetration of topically applied ciprofloxacin, norfloxacin and ofloxacin into the aqueous humor of the uninflamed human eye. , 1997, Journal of chemotherapy.
[31] H. Lazarus,et al. Topical fluoroquinolones: antimicrobial activity and in vitro corneal epithelial toxicity. , 1991, Current eye research.